Clik here to view.
辉凌医药宣布新的Olamkicept开发合作关系
瑞士圣普雷克斯 (美国商业资讯)–辉凌医药(Ferring Pharmaceuticals)今天宣布与I-Mab达成战略合作，进一步开发olamkicept在炎性肠病(IBD)和相关炎症中的应用。...
View ArticleClik here to view.
Quizartinib Plus Chemotherapy Significantly Improved Overall Survival...
TOKYO & BASKING RIDGE, N.J. Positive results from the global pivotal QuANTUM-First phase 3 trial of Daiichi Sankyo’s (TSE:5468) quizartinib combined with standard induction and consolidation...
View ArticleClik here to view.
BeiGene Announces BRUKINSA™ (zanubrutinib) Is Approved in 50 Markets
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and...
View ArticleClik here to view.
Guardant Health Completes Purchase of Guardant Health AMEA Joint Venture
PALO ALTO, Calif. Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced it has purchased the remaining shares of Guardant Health AMEA, Inc., held by SoftBank and...
View ArticleClik here to view.
Organon Enters into Global License Agreement to Commercialize Henlius’...
JERSEY CITY, N.J. Organon (NYSE: OGN), a global women’s health company with deep expertise in biosimilar commercialization, today announced that it has entered into an agreement with Shanghai...
View ArticleClik here to view.
Synopsis on the 1st IOF International Orthodontic Symposium
HONG KONG Orthodontics is the art of health and aesthetics that follows nature and portrays our pursuit of beauty. For thousands of years, orthodontists – the engineers and artists of orthodontics –...
View ArticleClik here to view.
Exscientia报告健康志愿者1a期研究的顶线数据，表明EXS-21546可靶向抑制A2A受体信号传导
英格兰牛津 (美国商业资讯)–Exscientia plc (Nasdaq: EXAI)今天发布其EXS-21546 1期健康志愿者研究数据。EXS-21546是由Exscientia和Evotec SE（法兰克福证券交易所：EVT,...
View ArticleClik here to view.
Guardant Health完成了对Guardant Health AMEA合资公司的收购
加州帕洛阿托 (美国商业资讯)–领先的精准肿瘤医学公司Guardant Health, Inc. (NASDAQ:GH)今天宣布，其已收购软银及其附属公司持有的Guardant Health AMEA, Inc.的剩余股份，从而使公司获得了对整个亚洲、中东和非洲(AMEA)地区业务的全面掌控。 据估计，世界上超过一半的新发癌症病例来自亚洲、中东和非洲(AMEA)。1此次收购将让Guardant...
View ArticleClik here to view.
ガーダントヘルスが合弁会社Guardant Health AMEAの買収を完了
米カリフォルニア州パロアルト （ビジネスワイヤ） — がん精密医療の大手企業であるガーダントヘルス（NASDAQ:GH）は本日、ソフトバンクとその関連会社が保有するGuardant Health AMEA, Inc.の残りの株式を購入し、アジア・中東・アフリカ地域全体の事業を完全に掌握したと発表しました。...
View ArticleClik here to view.
F45 Training Opens a New Chapter of Work-Life Balance for the Kwun Tong Workers
KWUN TONG, Hong Kong We are all aware of the importance of fitness activity. Many of us would like to participate, but we have a number of reservations. It seems difficult for workers to maintain a...
View ArticleClik here to view.
KBI Biopharma SA和Selexis SA在瑞士日内瓦启用一体化生物制剂设施，拓展欧洲市场
日内瓦 (美国商业资讯)–JSR Life Sciences旗下公司KBI Biopharma SA (KBI)和Selexis SA今天宣布，双方现已在瑞士日内瓦启用和运营一个经过扩建且完全一体化的哺乳动物合同开发和制造服务设施。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20220613005068/zh-CN/...
View ArticleClik here to view.
KBIバイオファーマとセレクシスがスイス・ジュネーブに統合的なバイオ医薬品製造施設を開設して欧州で拡大
ジュネーブ （ビジネスワイヤ） — いずれもJSRライフサイエンス傘下のKBIバイオファーマSA（KBI）とセレクシスは本日、スイスのジュネーブで完全統合型の哺乳類細胞受託開発製造サービス施設を拡張して開設したと発表しました。この施設は現在、稼働中です。...
View ArticleClik here to view.
GC Labs and Affiliates Participate in IFCC WorldLab Seoul 2022 as a Platinum...
YONGIN, South Korea GC Labs today announced that GC Labs and its affiliates including GC Cell, GC MS and GC Genome will participate in the IFCC WorldLab 2022 as a platinum sponsor held on 26-30 June...
View ArticleClik here to view.
HKSTP and Boehringer Ingelheim Venture Fund Launch Co-Incubation Programme to...
HONG KONG & INGELHEIM, Germany Hong Kong Science and Technology Parks Corporation (HKSTP) is partnering global research-driven biopharmaceutical leader, Boehringer Ingelheim Venture Fund Limited...
View ArticleClik here to view.
エクセンシア、健康なボランティアで選択的A2A受容体シグナル伝達阻害を示すEXS-21546の第1a相試験のトップラインデータを発表
英オックスフォード （ビジネスワイヤ） — エクセンシア（Nasdaq: EXAI）は本日、健康なボランティアでEXS-21546を検討する当社第1相試験から得たデータを発表しました。EXS-21546は、エクセンシアとイボテック（Frankfurt Stock Exchange: EVT、MDAX/TecDAX、ISIN: DE0005664809、Nasdaq:...
View ArticleClik here to view.
Kubota Vision Announced End of Phase 3 Clinical Trial of Emixustat in...
SEATTLE Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today the...
View ArticleClik here to view.
US FDA Approves Prestige Biopharma’s IND for Phase 1/2a Trial of...
SINGAPORE Prestige Biopharma Limited, a Singapore-based biopharmaceutical company with operations in USA and South Korea, announced that the U.S. Food and Drug Administration (FDA) has approved the...
View ArticleClik here to view.
Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin...
OSAKA, Japan & PASADENA, Calif. Takeda (TSE:4502/NYSE:TAK) (“Takeda”) and Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that results from a Phase 2 clinical study (AROAAT-2002)...
View ArticleClik here to view.
Kuria Therapeutics and SCOHIA PHARMA Announce Strategic Licensing Agreement...
KANAGAWA, Japan & LITTLE ROCK, Ark. Kuria Therapeutics, Inc., a US pharmaceutical company developing novel therapeutics for ophthalmic and dermal diseases, and SCOHIA PHARMA, Inc, a Japanese...
View ArticleClik here to view.
沃博联结束战略评估，决定保留表现优异的博姿业务
伊利诺伊州迪尔菲尔德 (美国商业资讯)–沃博联(Walgreens Boots Alliance, Inc., Nasdaq: WBA)今天宣布决定保留旗下现有的博姿(Boots)和No7 Beauty Company业务。这标志着沃博联正式结束了从今年一月开始的公司战略重点评估。 沃博联此前曾与多方进行卓有成效的磋商，其中有潜在买家对收购博姿和No7 Beauty...
View Article